Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1998-2-27
|
pubmed:abstractText |
Studies of the CD25 gene promoter region in T cells have revealed the presence of a 31-bp region, including an 11-bp negative regulatory element (NRE), which profoundly suppresses CD25 expression. This report illustrates that the same region acts as a negative regulator of CD25 expression in human B lymphocytes. Human B cells contain DNA-binding protein activities which bind specifically to an oligonucleotide equivalent to the 11-bp core region of the NRE, and stimulation of tonsillar B cells or Daudi Burkitt's lymphoma B cells with interleukin 4 (IL-4) results in loss of binding activity for oligonucleotides containing the NRE; in contrast, IL-4 enhanced binding activity for the NRE in the Jurkat T cell line. Transient transfection analyses using deletion mutants lacking both the 11-bp core NRE and both the NRE and an adjacent putative retinoic acid response element (RARE) motif illustrated that the NRE element is a functional suppressor of CD25 transcription in B cells. Thus, deletion of the NRE element increased the basal level of CD25 promoter activity and also conferred IL-4 inducibility on reporter gene expression in transiently transfected tonsillar B lymphocytes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chloramphenicol O-Acetyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1043-4666
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1997 Academic Press Limited.
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
982-91
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9417809-B-Lymphocytes,
pubmed-meshheading:9417809-Base Sequence,
pubmed-meshheading:9417809-Chloramphenicol O-Acetyltransferase,
pubmed-meshheading:9417809-DNA-Binding Proteins,
pubmed-meshheading:9417809-Genes, Reporter,
pubmed-meshheading:9417809-Humans,
pubmed-meshheading:9417809-Interleukin-4,
pubmed-meshheading:9417809-Jurkat Cells,
pubmed-meshheading:9417809-Palatine Tonsil,
pubmed-meshheading:9417809-Polymerase Chain Reaction,
pubmed-meshheading:9417809-Promoter Regions, Genetic,
pubmed-meshheading:9417809-Receptors, Interleukin-2,
pubmed-meshheading:9417809-Recombinant Fusion Proteins,
pubmed-meshheading:9417809-Regulatory Sequences, Nucleic Acid,
pubmed-meshheading:9417809-T-Lymphocytes,
pubmed-meshheading:9417809-Transfection,
pubmed-meshheading:9417809-Tretinoin
|
pubmed:year |
1997
|
pubmed:articleTitle |
Negative regulation of the interleukin (IL)-2 receptor alpha chain (CD25) promoter region in human B lymphocytes.
|
pubmed:affiliation |
Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|